Skip to main content
2023 ACVIM Forum Main banner
Final Program


2023 Event Program
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
ePoster
ePoster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
RACE-Approved
RACE-Approved
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
State-of-the-Art (SOTA) Presentation
State-of-the-Art (SOTA) Presentation
Veterinary Technician
Veterinary Technician
Back
Evaluation ViewAttendees 25

Multispecialty

Technician Luncheon: Laverdia-CA1: What Types of Cases Could It Be a Good Fit For?

Friday, June 16, 2023
12:00 PM – 1:30 PM ET
Location: Marriott Ballroom Salon G, 5th Level
CE: 1.5

Sponsored by 
Pre-Registration Required Veterinary Technician
Laverdia-CA1 (verdinexor) is a recent addition for veterinary oncology. This discussion will explore how the drug works as well as what types of canine lymphoma cases could be appropriate to consider Laverdia-CA1.

Learning Objectives:

  • ) Learner will understand the basics of how Laverdia-CA1 works
  • Learner will understand several different types of cases that Laverdia-CA1 could be offered as a treatment option.
  • Upon completioon attendees will be able to define canine lymphoma